These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 12665807)

  • 1. US Patent Office strategic plan may penalize biotechs.
    Robertson D
    Nat Biotechnol; 2003 Apr; 21(4):345-6. PubMed ID: 12665807
    [No Abstract]   [Full Text] [Related]  

  • 2. The coming US patent opposition.
    Apple T
    Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151
    [No Abstract]   [Full Text] [Related]  

  • 3. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 5. Inter partes reexamination: a potentially useful approach to challenging invalid biotechnology patents.
    Derzko NM; Behringer JW
    Nat Biotechnol; 2003 Jul; 21(7):823-5. PubMed ID: 12833101
    [No Abstract]   [Full Text] [Related]  

  • 6. Patent office plan to beat its backlog elicits cool response.
    Powell K
    Nature; 2002 Sep; 419(6903):100. PubMed ID: 12226625
    [No Abstract]   [Full Text] [Related]  

  • 7. India's IP snub.
    Jayaraman KS
    Nat Biotechnol; 2008 Apr; 26(4):362. PubMed ID: 18392000
    [No Abstract]   [Full Text] [Related]  

  • 8. Genomics companies welcome US PTO initiative on DNA patents.
    Marshall A
    Nat Biotechnol; 1997 Feb; 15(2):121-2. PubMed ID: 9035129
    [No Abstract]   [Full Text] [Related]  

  • 9. Proposal for US patent office could help cut waiting time.
    Smaglik P
    Nature; 2000 Jul; 406(6794):334. PubMed ID: 10935603
    [No Abstract]   [Full Text] [Related]  

  • 10. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 11. Intellectual property protection for plant-related inventions in Europe.
    Fleck B; Baldock C
    Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of patent interferences in gene technology.
    Merz JF; Henry MR
    Nat Biotechnol; 2004 Feb; 22(2):153-4. PubMed ID: 14755283
    [No Abstract]   [Full Text] [Related]  

  • 13. The patent gamble: strategic insights for playing the worldwide patent game.
    Barrett WA
    Nat Biotechnol; 2003 Dec; 21(12):1515-7. PubMed ID: 14647335
    [No Abstract]   [Full Text] [Related]  

  • 14. Agbiotech issues climb US political agenda.
    Fox JL
    Nat Biotechnol; 2002 Dec; 20(12):1179-80. PubMed ID: 12454658
    [No Abstract]   [Full Text] [Related]  

  • 15. Errors in patent application sequence listings.
    Jones R
    Nat Biotechnol; 2003 Oct; 21(10):1239-40. PubMed ID: 14520406
    [No Abstract]   [Full Text] [Related]  

  • 16. Major patent reform moves closer.
    Hughes B
    Nat Rev Drug Discov; 2007 Sep; 6(9):688-9. PubMed ID: 17907341
    [No Abstract]   [Full Text] [Related]  

  • 17. Cash crunch quells antibody litigation.
    Mitchell P
    Nat Biotechnol; 2003 Feb; 21(2):114-5. PubMed ID: 12560822
    [No Abstract]   [Full Text] [Related]  

  • 18. Brussels takes EU states to court over biopatent law.
    Habeck M
    Nat Biotechnol; 2003 Sep; 21(9):960. PubMed ID: 12949544
    [No Abstract]   [Full Text] [Related]  

  • 19. Cabilly patent finale.
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):846. PubMed ID: 18688222
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzo Biochem v. Gen-Probe: complying with the written description requirement under US patent law.
    Blaug S; Shuster M; Su H
    Nat Biotechnol; 2003 Jan; 21(1):97-9. PubMed ID: 12511910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.